Latest Articlesddd
The media failure to forecast the results of the Presidential election has become the talk of …
Biogen (BIIB) and Ionis (IONS) announced that Spinraza (nusinersen), an antisense drug designed and developed by …
The nature the Presidential Election this time is weighing on investors’ chests and minds and mood …
Ariad Pharmaceuticals (ARIA): Good news from the U.S. Food and Drug Administration (FDA) affirmed that the …
Regeneron (REGN) and Sanofi informed that the FDA has issued a Complete Response Letter (CRL) regarding …
Prohost Letter #400 NEAR-TERM INVESTING The Prohost Letter #399 Part 3 has Promised to Des
Results from trials were negative in two phase 2 studies for Gilead (GILD) experimental drug GS-4997 …
There is nothing wrong with Nektar Therapeutics (NKTR). The stock is temporarily underperforming as traders are …
At the Annual European Congress of Rheumatology (EULAR 2016) in London, Eli Lilly and Company (LLY) …
Shares of Ariad Pharmaceuticals declined following Senator Bernie Sanders’ criticism of the high price of the …
When plenty of news comes out of the biotech sector, we are left with no option …
EXELIXIS APPROVED PRODUCTS 1. CABOMETYX™(CABOZANTINIB) For Exelixis (EXEL) the two approved oncology products cabozantinib and cobimetinib …
Following recent reports of new onset or worsening peripheral neuropathy in patients with ATTR amyloidosis with …
News about investigational drugs, which are expected to make big differences in the lives of people …
EXELIXIS (EXEL) Friends and subscribers are asking the following question for more than two weeks now: …
The FDA approval of Sarepta’s (SRPT) Duchenne muscular dystrophy (DMD) product, Exondys 51 (eteplirsen), surprised many …
As we expected in our previous articles, Today, Aerie Pharmaceuticals (AERI) came up with great news …
Another gene editing firm, CRISPR Therapeutics decided to become publicly traded. On Friday, the private firm …
The FDA announced what made Clovis Oncology (CLVS) shareholders believe that the bad times might have …
Xoma’s (XOMA) webcast and conference call scheduled for September 15, 2016, at 1:30 p.m. PDT (4:30 …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
